MeSH Browser

MeSH Supplementary: CE protocol II
Unique ID: C505030
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C505030
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin
Frequency: 2
Note: chemotherapy protocol consisting of above compounds, used in treatment of early breast cancer patients
Source: J Clin Oncol. 2005 Oct 1;23(28):6908-18
Date of Entry: 2005/11/01

CE protocol II MeSH Supplementary Concept Data 2024